Pacira BioSciences, Inc. (PCRX) — Net Asset Quality Index
Pacira BioSciences, Inc. (PCRX) has a Net Asset Quality Index of 54.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.24 Billion minus total liabilities of $572.01 Million yields net assets of $671.97 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Pacira BioSciences, Inc. for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pacira BioSciences, Inc. Net Asset Quality Index Over Time (2008–2025)
This chart shows how Pacira BioSciences, Inc.'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 54.0%, representing net assets of $671.97 Million against total assets of $1.24 Billion USD. For live market cap and overall valuation, see PCRX market cap overview.
Annual Net Asset Quality Index for Pacira BioSciences, Inc. (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Pacira BioSciences, Inc. from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check PCRX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.8% | $693.11 Million | $1.26 Billion | $571.81 Million | ▲ +4.7 pp |
| 2024 | 50.1% | $778.35 Million | $1.55 Billion | $775.17 Million | ▼ -5.2 pp |
| 2023 | 55.3% | $870.13 Million | $1.57 Billion | $704.26 Million | ▲ +9.2 pp |
| 2022 | 46.1% | $775.01 Million | $1.68 Billion | $906.19 Million | ▲ +10.9 pp |
| 2021 | 35.2% | $730.41 Million | $2.08 Billion | $1.34 Billion | ▼ -13.4 pp |
| 2020 | 48.6% | $619.69 Million | $1.27 Billion | $654.83 Million | ▲ +5.9 pp |
| 2019 | 42.7% | $354.94 Million | $831.07 Million | $476.12 Million | ▼ -3.9 pp |
| 2018 | 46.6% | $321.23 Million | $689.35 Million | $368.13 Million | ▲ +2.1 pp |
| 2017 | 44.5% | $279.48 Million | $628.37 Million | $348.89 Million | ▼ -11.5 pp |
| 2016 | 55.9% | $218.98 Million | $391.47 Million | $172.49 Million | ▼ -0.1 pp |
| 2015 | 56.1% | $218.39 Million | $389.62 Million | $171.23 Million | ▲ +3.6 pp |
| 2014 | 52.5% | $171.15 Million | $326.07 Million | $154.93 Million | ▲ +28.2 pp |
| 2013 | 24.3% | $41.25 Million | $169.82 Million | $128.57 Million | ▼ -34.5 pp |
| 2012 | 58.8% | $65.86 Million | $112.05 Million | $46.20 Million | ▲ +16.2 pp |
| 2011 | 42.5% | $48.27 Million | $113.49 Million | $65.22 Million | ▲ +115.2 pp |
| 2010 | -72.7% | $-48.38 Million | $66.56 Million | $114.94 Million | ▼ -20.5 pp |
| 2009 | -52.2% | $-22.95 Million | $43.95 Million | $66.90 Million | ▼ -67.0 pp |
| 2008 | 14.8% | $7.49 Million | $50.54 Million | $43.05 Million | — |